<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45410">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02150226</url>
  </required_header>
  <id_info>
    <org_study_id>FZ001</org_study_id>
    <nct_id>NCT02150226</nct_id>
  </id_info>
  <brief_title>Y-TZP and In-mouth Low Thermal Degradation A Prospective Clinical Study</brief_title>
  <official_title>Y-TZP and In-mouth Low Thermal Degradation: A Prospective Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DMG Paris Descartes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital of Liege</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this work is to study in-mouth aging and LTD of monolithic zirconia
      restorations. Microstructural changes characteristic of LTD processes, wear, and clinical
      behaviour following standard parameters will be evaluated. Notably Raman spectroscopy and 3D
      laser surface analysis will be used, directly on the restorations, which will be removed at
      regular intervals.The working hypothesis is that LTD process is very slow at the scale at
      the lifespan of dental prostheses.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Zirconia monolithic restorations in-vivo and in-vitro evaluation</measure>
    <time_frame>up to 5 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Zirconia Monolithic Dental Crowns and Bridges In-vivo Behaviour and Ageing.</condition>
  <arm_group>
    <arm_group_label>Zirconia monolithic crowns and bridges</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>evaluation of Lava Plus zirconia dental crowns and bridges</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lava plus (3M) crowns and bridges</intervention_name>
    <description>Zirconia monolithic dental crowns and bridges evaluation</description>
    <arm_group_label>Zirconia monolithic crowns and bridges</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Full zirconia crowns in the posterior region (molar/premolar)

          -  On teeth or implants

          -  Single unit restorations cemented on natural teeth and implants (including
             screw-retained restorations if possible, but no internal connections)

          -  Multi-unit restorations on implants

          -  If nightguard: to be performed on the antagonist

        Exclusion Criteria:

          -  Patients with removable prosthesis as an antagonist
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Dentistry University of Liege</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amélie Mainjot</last_name>
      <email>a.mainjot@chu.ulg.ac.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 28, 2014</lastchanged_date>
  <firstreceived_date>May 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Liege</investigator_affiliation>
    <investigator_full_name>Mainjot Amélie</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
